Mark S. Cohen

Mark S. Cohen

Président chez Tarus Therapeutics, Inc.

56 ans
Health Technology
Consumer Services
Commercial Services

Provenance du réseau au premier degré de Mark S. Cohen

EntitéType d'entitéIndustrie
6
Subsidiary Pharmaceuticals: Major 6

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Mark S. Cohen via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
ARQULE, INC. Pharmaceuticals: Major

Paolo Pucci

Chief Executive Officer

RUBIUS THERAPEUTICS Biotechnology

David Epstein

Chairman

Investment Managers

David Epstein

Private Equity Investor

Packaged Software

David Epstein

Director/Board Member

Financial Conglomerates

David Epstein

Director/Board Member

Pharmaceuticals: Major

David Epstein

Director/Board Member

Pharmaceuticals: Generic

David Epstein

Corporate Officer/Principal

Remedii LLC

David Epstein

Corporate Officer/Principal

AXCA HEALPAR Biotechnology

David Epstein

Chairman

EVELO BIOSCIENCES, INC. Pharmaceuticals: Major

David Epstein

Chairman

Pharmaceuticals: Major

David Epstein

Director/Board Member

Three Opinions Foundation, Inc.

David Epstein

Director/Board Member

Medical Specialties

David Epstein

Director/Board Member

INTERNATIONAL FLAVORS & FRAGRANCES INC. Food: Specialty/Candy

David Epstein

Director/Board Member

Columbia Business School College/University

David Epstein

Masters Business Admin

NOVARTIS AG Pharmaceuticals: Major

David Epstein

Corporate Officer/Principal

Pharmaceuticals: Major

David Epstein

Chief Executive Officer

Miscellaneous Commercial Services

David Epstein

Corporate Officer/Principal

Pharmaceuticals: Major

David Epstein

Chief Executive Officer

OPY ACQUISITION CORP. I Financial Conglomerates

David Epstein

Director/Board Member

Agricultural Commodities/Milling

David Epstein

Chairman

TRYPTAMINE THERAPEUTICS LIMITED Pharmaceuticals: Major

Peter Molloy

Corporate Officer/Principal

Harvard Medical School College/University

Robert Glassman

Doctorate Degree

Financial Conglomerates

Robert Glassman

Private Equity Investor

Weill Cornell Medical College College/University

Robert Glassman

Corporate Officer/Principal

Pharmaceuticals: Major

Robert Glassman

Director/Board Member

Pharmaceuticals: Major

Robert Glassman

Director/Board Member

Bank of America Merrill Lynch (New York)

Robert Glassman

Corporate Officer/Principal

Regional Banks

Robert Glassman

Director/Board Member

PHARVARIS N.V. Pharmaceuticals: Major

Robert Glassman

Director/Board Member

Pharmaceuticals: Major

Robert Glassman

Director/Board Member

Harvard College College/University

Robert Glassman

Undergraduate Degree

The Rockefeller University College/University

Robert Glassman

Corporate Officer/Principal

Ernest Mario School of Pharmacy College/University

David Epstein

Undergraduate Degree

Miscellaneous Commercial Services

Robert Glassman

Corporate Officer/Principal

Investment Managers

Robert Glassman

Private Equity Investor

Pharmaceuticals: Major

David Epstein

Director/Board Member

Packaged Software

David Epstein

Director/Board Member

SEAGEN INC. Pharmaceuticals: Major

David Epstein

Chief Executive Officer

Pharmaceuticals: Major

David Epstein

Director/Board Member

SENTI BIOSCIENCES, INC. Biotechnology

David Epstein

Director/Board Member

Pharmaceuticals: Major

David Epstein

Director/Board Member

Miscellaneous Commercial Services

Peter Molloy

Corporate Officer/Principal

The University of Exeter College/University

Peter Molloy

Undergraduate Degree

Bayer Pharmaceuticals Corp.

Paolo Pucci

Corporate Officer/Principal

MERUS N.V. Biotechnology

Paolo Pucci

Director/Board Member

Statistiques

Internationale

Etats-Unis 39
Suisse 5
Royaume-Uni 4
Pays-Bas 3
Canada 2

Sectorielle

Health Technology 23
Finance 9
Consumer Services 8
Commercial Services 4
Technology Services 3

Opérationnelle

Director/Board Member 50
Corporate Officer/Principal 26
Independent Dir/Board Member 23
Chief Executive Officer 8
Chairman 7
  1. Bourse
  2. Insiders
  3. Mark S. Cohen
  4. Connexions Sociétés